Utility of Remote Lung Auscultation in Transitions of Care After Pulmonary Exacerbations of COPD

Launched by STRADOS LABS, INC. · Dec 14, 2022

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Males and females between the ages of 35 and 75 with documented physician-diagnosed COPD
• • 2. Hospitalization with a primary diagnosis of COPD with exacerbation or pneumonia.
• • 3. Patient able and willing to provide informed consent.
• • 4. Patient can follow study procedures, including instructions for self-placement and operation of device
• • a. Patient has experience using a smartphone
• • 5. Accessible by telehealth/telephone upon discharge
• • 6. Patient is able and willing to return to study site for study follow-up visits as necessary
• Exclusion Criteria:
• • 1. Patient unable or unwilling to provide informed consent
• • 2. Diagnosis of COPD is uncertain
• • 3. Plan for discharge to location other than the patient's home (eg, Nursing Home, Rehabilitation facility)
• • 4. Patient with end-stage medical condition with expected survival no more than 3 months
• • 5. History of adverse reaction or allergy to TegaDerm®
• • 6. Inaccessible by telehealth/telephone post discharge